Clofezone anhydrous

This classification denotes the anhydrous form of a nonsteroidal antiinflammatory drug with the molecular formula C19H20N2O2.C14H21ClN2O2.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TPT3MH65LD, chemically known as 2-(4-chlorophenoxy)-n-(2-(diethylamino)ethyl)acetamide, compound with 4-butyl-1,2-diphenyltetrahydropyrazol-3,5-dione (1:1) but more generally known as clofezone, which bears US NIH Compound Identifier 6433695. European Medicines Agency schedules Clofezone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06705MIG. World Health Organization schedules clofezone in its Anatomical Therapeutic Chemical (ATC) Classification. CLOFEZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule clofezone anhydrous under HS 29331990. As of Q4 2014, CLOFEZONE ANHYDROUS remains US FDA's Preferred Term for this commodity. SMILES: CCCCC1C(=O)N(N(C1=O)C2CCCCC2)C3CCCCC3.CCN(CC)CCNC(=O)COC1CCC(CC1)CL.